Results 251 to 260 of about 35,117 (307)
Some of the next articles are maybe not open access.
International Anesthesiology Clinics, 1994
In an editorial, Kapur [4] described perioperative nausea and vomiting as the big "little problem following ambulatory surgery." In contrast to the attitudes of some physicians, patients put a high value on freedom from nausea and emesis in the postoperative period and are willing to accept some pain and drowsiness as the cost of controlling PONV [85].
Paul F. White, Mehernoor F. Watcha
openaire +2 more sources
In an editorial, Kapur [4] described perioperative nausea and vomiting as the big "little problem following ambulatory surgery." In contrast to the attitudes of some physicians, patients put a high value on freedom from nausea and emesis in the postoperative period and are willing to accept some pain and drowsiness as the cost of controlling PONV [85].
Paul F. White, Mehernoor F. Watcha
openaire +2 more sources
Corticosteroids as Antiemetics
1988Although several antiemetic agents can exert some control of cancer chemotherapy-related nausea and vomiting, none is totally effective. As in many other instances of medical treatment, combinations of drugs will probably prove the best means of controlling the situation.
openaire +3 more sources
Current Opinion in Oncology, 1992
Despite major progress in the treatment of chemotherapy-induced emesis, nearly one third of patients undergoing cisplatin-based regimens still experience emesis within the first 24 hours of chemotherapy. An adequate treatment of delayed and anticipatory emesis remains to be determined.
openaire +2 more sources
Despite major progress in the treatment of chemotherapy-induced emesis, nearly one third of patients undergoing cisplatin-based regimens still experience emesis within the first 24 hours of chemotherapy. An adequate treatment of delayed and anticipatory emesis remains to be determined.
openaire +2 more sources
Journal of Palliative Care, 1993
The choice of antiemetic should not be arbitrary, but should be based on knowledge of the different pathways of the various stimuli that lead to nausea and vomiting and the neuroreceptors involved. The steps to be taken in choosing an appropriate antiemetic are described.
openaire +2 more sources
The choice of antiemetic should not be arbitrary, but should be based on knowledge of the different pathways of the various stimuli that lead to nausea and vomiting and the neuroreceptors involved. The steps to be taken in choosing an appropriate antiemetic are described.
openaire +2 more sources
Methodology of trials with antiemetics
Supportive Care in Cancer, 1996Chemotherapy-induced nausea and vomiting can today be controlled with the "new" antiemetics or with their various combinations in a high percentage of patients. Despite this, for some subgroups of patients, certain chemotherapy regimens and some aspects of the phenomenon (delayed presentation), emesis remains a critical problem.
Enzo Ballatori +3 more
openaire +3 more sources
Efficacy and safety of antiemetics
Cancer Treatment Reviews, 1994Of all the adverse effects associated with cancer chemotherapy, patients find nausea and vomiting the most distressing (I, 2). Indeed, nausea and vomiting continue to be critical problems in cancer chemotherapy. They can lead to a dramatic deterioration of the patients’ quality of life and result in up to 50% of patients delaying or missing treatment ...
Michel Marty, Volker Diehl
openaire +3 more sources
Antiemetics, Akathisia, and Pregnancy
Psychosomatics, 2007Gastrointestinal disorders are common in pregnant women. These disorders are often treated with antiemetic medications that block central dopaminergic neurotransmission. Dopamine antagonists can cause akathisia. Hormonal changes and other factors may place pregnant women at increased risk for the development of severe antiemetic-induced akathisia.
openaire +2 more sources
Myths of antiemetic administration
Cancer Nursing, 1989Chemotherapy as a treatment modality for cancer has dramatically improved outcomes for patients. However, to attain therapeutic benefit, side effects and toxicities must be endured. Among the most frequent and distressing side effects are nausea and vomiting. The experience of nausea and vomiting may become so devastating that patients will discontinue
openaire +2 more sources
The latest consensus on antiemetics
Current Opinion in Oncology, 2018Purpose of review The present review summarizes and discuss the most recent updated antiemetic consensus. Recent findings Two new neurokinin (NK)1-receptor antagonists, netupitant and rolapitant, have been approved by the Food and Drug Administration and the European Medicines ...
openaire +4 more sources